QuANTUM-First  MRD Analysis
Phase III QuANTUM-First: Prognostic Value of FLT3-ITD–Specific MRD Clearance at Induction/Consolidation Using Chemotherapy With or Without Quizartinib in Patients With AML

Released: December 15, 2023

Activity

Progress
1
Course Completed